BIOVENTUS Quarterly Earnings Announcement and Recent Insider Activity

BIOVENTUS ($BVS) is set to report its quarterly earnings on Tuesday, March 11th, before the market opens, according to Finnhub. Analysts predict revenue will reach $146,618,336, with earnings projected at $0.08 per share.

Visit Quiver Quantitative’s $BVS Stock page for insights on insider trading, hedge fund movements, congressional trading, and more.

Recent Insider Trading at BIOVENTUS

In the past six months, insiders at BIOVENTUS have executed 7 trades of $BVS Stock. Notably, all these trades were sales, with no purchases reported.

Here’s a recap of recent insider trading activities:

• ROBERT E CLAYPOOLE (President and CEO) sold 28,786 shares for approximately $261,952.
• MARK LEONARD SINGLETON (SVP & CFO) sold 17,231 shares for about $179,233.
• ANTHONY D’ADAMIO (SVP & General Counsel) sold 10,228 shares for around $106,211.
• KATRINA J CHURCH (SVP & Chief Compliance Officer) sold 4,072 shares for an estimated $42,355.

For ongoing updates on insider transactions, refer to Quiver Quantitative’s insider trading dashboard.

Institutional Investment Trends in BIOVENTUS

In the latest quarter, 79 institutional investors increased their holdings in BIOVENTUS, while 83 reduced their positions.

Highlighted below are significant recent moves:

• FMR LLC added 802,155 shares (+480.9%) in Q4 2024, valued at approximately $8,422,627.
• VANGUARD GROUP INC increased their holdings by 388,174 shares (+18.7%) in Q4 2024, amounting to about $4,075,827.
• MORGAN STANLEY reduced their portfolio by 365,074 shares (-36.2%) in Q4 2024, worth approximately $3,833,277.
• PURA VIDA INVESTMENTS, LLC completely exited with a reduction of 352,569 shares (-100.0%) in Q4 2024, valued at about $3,701,974.
• NANTAHALA CAPITAL MANAGEMENT, LLC decreased by 324,061 shares (-7.4%) in Q4 2024, valued at approximately $3,402,640.
• INVESCO LTD. also reduced their holdings significantly, with 323,850 shares (-94.4%) removed in Q4 2024, worth about $3,400,425.
• BRIDGEWAY CAPITAL MANAGEMENT, LLC divested completely by removing 313,804 shares (-100.0%) in Q3 2024, valued at around $3,749,957.

For more information on hedge fund activities, visit Quiver Quantitative’s institutional holdings dashboard.

BIOVENTUS Government Contracts Overview

Over the past year, BIOVENTUS has received a total of $33,970 in award payments.

Highlighted below are some of the most significant awards received in the last year:

To view government contracts awarded to publicly traded companies, explore Quiver Quantitative’s government contracts dashboard.

This article does not constitute financial advice. For further information, refer to Quiver Quantitative’s disclaimers. Note that inaccuracies may arise due to ticker-mapping errors and other discrepancies.

This article was originally published on Quiver News; follow the link for the complete story.

The views and opinions expressed herein are solely those of the author and do not necessarily reflect those of Nasdaq, Inc.